The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Indian aqua inputs and supplements (for shrimps) market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 14.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Aqua inputs and supplements refer to the chemical substances, including antibiotics, that are utilized for shrimp health management. These substances protect shrimps from vibriosis and other luminescent bacteria, along with preventing any disease outbreak during the farming period. In India, these chemicals are increasingly being used in shrimp aquaculture to ensure a healthy and sustainable environment for shrimp.
Over the years, India has emerged as one of the leading shrimp producers in the world which has given a boost to the aquaculture activities in the country. In addition to this, the rising consumer health consciousness has led to a shift from high-calorie diet to protein-rich seafood, such as shrimps. Owing to this, several manufacturers are introducing improved and effective chemical products targeting shrimp aquaculture. Moreover, India is also one of the low-cost producers of medicines, drugs, and supplements, this has enabled India to become an economical producer of aqua inputs and supplements, thereby proliferating the export activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the Indian aqua inputs and supplements (for shrimps) market, along with forecasts at the country and state level from 2021-2026. Our report has categorized the market based on end-use and product type.
Breakup by End-Use:
Breakup by Product Type:
Breakup by States:
The competitive landscape of the industry has also been examined with some of the key players being Bayer CropScience Limited, Biostadt India Limited, C. P. Aquaculture (INDIA) Private Limited, Growel Formulations Pvt. Ltd., Gentle Bio-Sciences Pvt. Ltd., Hi-Tech Pharma, Intas Animal Health, Kemin Industries South Asia Pvt. Ltd, Neospark Drugs and Chemicals Private Limited, Poseidon Biotechnology, PVS Group, Srinivasa Cystine Pvt. Ltd., Sanzyme Biologics, SDC Agro-Vet India Pvt. Ltd., Synergy Biotechnologies, Virbac Animal Health India Private Limited, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||End-Use, Product Type, States|
|States Covered||Andhra Pradesh, West Bengal, Odisha, Gujarat|
|Companies Covered||Bayer CropScience Limited, Biostadt India Limited, C. P. Aquaculture (INDIA) Private Limited, Growel Formulations Pvt. Ltd., Gentle Bio-Sciences Pvt. Ltd., Hi-Tech Pharma, Intas Animal Health, Kemin Industries South Asia Pvt. Ltd, Neospark Drugs and Chemicals Private Limited, Poseidon Biotechnology, PVS Group, Srinivasa Cystine Pvt. Ltd., Sanzyme Biologics, SDC Agro-Vet India Pvt. Ltd., Synergy Biotechnologies and Virbac Animal Health India Private Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 1999
Five User License $ 2999
Corporate License $ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at